The U.S. Food and Drug Administration mentioned it has seized “thousands of units” of counterfeit Ozempic, the diabetes drug extensively used for weight reduction, that had been distributed by means of reputable drug provide sources.
The FDA and the drug’s maker, Novo Nordisk, are testing the pictures. They don’t but have details about the medicine’ id, high quality or security, in response to a press release. Five diseases have been linked to the pretend pictures, however none have been severe, the FDA mentioned Thursday.
Some of the pretend 1 milligram semaglutide pictures should still be on the market, FDA mentioned. In addition to the drug itself, the needles, pen labels, carton and accompanying well being care info are additionally counterfeit, the company mentioned.
It mentioned the counterfeits had been labeled with the lot quantity NAR0074 and serial quantity 430834149057.
FDA suggested retail pharmacies to purchase genuine Ozempic solely by means of approved distributors and for sufferers to get it solely by means of state-licensed pharmacies.
Consumers can report suspect Ozempic packages by calling 800-332-1088 or by contacting a state grievance coordinator.
